Demystifying Radiosurgery (SBRT) for Prostate Cancer
What is it and why do you need to know about it?
June 6, 2012
Lee E. Ponsky, MD
Associate Professor, Urology
University Hospitals Case Medical Center
Cleveland, OH
Demystifying Radiosurgery (SBRT) for Prostate cancer.
What is it and why do you need to know about it?
— Supported by an educational grant from Accuray
Originally broadcast July 20, 2012
Statement of Purpose:
Hypofractionated, stereotactic body radiotherapy (SBRT) is an emerging treatment option for prostate cancer patients. The recent technological advancements have allowed precise targeting and delivery of radiation to the moving prostate while sparing normal tissues. This leads to the potential to reduce treatment-related morbidity and maintain quality of life following prostate cancer treatment. In this webinar, Dr. Lee Ponsky will review the clinical rationale for SBRT for prostate cancer and discuss his experiences treating patients at UH Case Medical Center.
Learning Objectives:
Upon completion of this activity, participants will be able to:
Recognize the clinical rationale for stereotactic body radiation therapy for prostate cancer
Review the clinical data supporting SBRT for early stage prostate cancer
Identify patients for whom SBRT might be an appropriate treatment option
Discuss the details of this treatment option with their patients
Intended Audience:
Urologists and radiation oncologists.
Speaker:
Lee E. Ponsky, M.D.
Associate Professor, Urology
University Hospitals Case Medical Center
Cleveland, Ohio
To test if your computer meets the hardware/software requirements to view this webcast, please click on the SYSTEM TEST tab above.
If you have any technical questions please click on the HELP tab above.
Disclosure information:
Dr. Lee E. Ponsky
Accuray Inc.: Data Safety Monitoring Board; Tengion Inc: Data Safety Monitoring Board; U.S. Endoscopy: Consultant; Varian Medical Systems: Consultant
Accuray Inc.: Data Safety Monitoring Board; Tengion Inc: Data Safety Monitoring Board; U.S. Endoscopy: Consultant; Varian Medical Systems: Consultant
Discussion of off-label, investigational or experimental drug-use: None
The Academy for Continued Healthcare Learning and Scranton Gillette Communications staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
More like this
- Prostate SBRT: Outcomes and Experiences
- Multi-Site Study to Evaluate Targeted Radiation for Prostate
- CyberKnife Prostate SBRT Data Presented at American Urological Association Meeting
- Low Dose Mammography with Photon Counting
- Study Highlights Stereotactic Body Radiotherapy for Noninvasive Brachytherapy-like Treatment for Prostate Cancer
Archived Webinars
Submitted by dfornell on August 8, 2012 - 11:58am.
Steve, just register at the link for the webinar and it should allow you to view the webinar. Our webinars are archived for a year after they originally aire.
Thanks - Dave Fornell, editor
Please send me information on
Submitted by Steve Carpenter, MD (not verified) on August 4, 2012 - 5:11pm.
Please send me information on viewing archived webinars.
utility and futility of surgery in prostate cancer
Submitted by DR.P.L.NAWALKHA (not verified) on July 10, 2012 - 7:36pm.
SBRT IS A MOST REWARDING,INNOCUOUS PROCEDURE,ONE LEAP FORWARD IN MANAGEMENT OF CANCER.OF PROSTATE